Analyst firms · Wolfe Research · BRKR

Wolfe Research BRKR price target and rating history

Bruker Corporation (BRKR) · Health Care

Wolfe Research rates Bruker Corporation (BRKR) Peer Perform with a $60 price target, as of its latest action on Jun 2, 2026. It has published 4 rating actions on BRKR since December 2023, including 1 upgrade and 1 downgrade. Across 4 firms with a BRKR price target in the last 12 months, the median target is $62.50. Wolfe Research's $60 is 4% below that.

Current rating
Peer Perform
Price target
$60
Median target, all firms
$62.50
Actions on BRKR
4

Wolfe Research price target on BRKR

$80$70$60202420252026
Wolfe Research price target on BRKR, each point a stated target, December 2023 to December 2025.

Every Wolfe Research rating on BRKR

How other firms rate BRKR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsSector Perform$66Nov 20, 2026
UBSNeutral$65Sep 9, 2026
Wolfe ResearchPeer Perform$60Jun 2, 2026
Goldman SachsSell$40Dec 9, 2025

Questions about Wolfe Research and BRKR

What is Wolfe Research's price target for BRKR?
Wolfe Research's latest stated price target for Bruker Corporation (BRKR) is $60, from its action on Dec 10, 2025.
What is Wolfe Research's rating on BRKR?
Wolfe Research rates BRKR Peer Perform, a neutral rating, as of Jun 2, 2026.
When did Wolfe Research last change its view on BRKR?
On Jun 2, 2026, Wolfe Research resumes coverage at Peer Perform.
How does Wolfe Research's BRKR target compare with other analysts?
Across 4 firms with a BRKR price target in the last 12 months, the median target is $62.50. Wolfe Research's $60 is 4% below that.

More BRKR rating histories

All Wolfe Research ratingsBRKR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.